- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Digitizer firm finds new home
Vidar System, widely known as a manufacturer of medical film digitizers, has been acquired by Contex Holdings of Allerød, Denmark. Contex, a maker of large-format scanners, is owned by EQT, a group of Scandinavian private equity funds. Contex and Vidar
Vidar System, widely known as a manufacturer of medical film digitizers, has been acquired by Contex Holdings of Allerød, Denmark. Contex, a maker of large-format scanners, is owned by EQT, a group of Scandinavian private equity funds. Contex and Vidar have been competitors in the development and distribution of large-format image scanning equipment. Vidar has also established itself as the leading producer of medical x-ray digitizers for diagnosis and treatment applications. The merged company will have combined revenues for 2002 exceeding US$50 million. Strategists plan to focus on the medical imaging products segment, while Contex concentrates on large-format imaging applications. Vidar will continue to design, develop, and distribute its range of medical products under Vidar brand from its facility in Herndon, VA.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
